Activation of the Thrombopoietin Receptor by Mutant Calreticulin in CALR-Mutant Myeloproliferative Neoplasms

Results from a recent study indicate that mutant CALR may promote myeloproliferative neoplasm development by activating c-MPL and its downstream pathway.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.